Ciro Pharma invests Rs 800 Cr to open India’s first integrated oncology manufacturing facility in Hyderabad

Ciro Pharma has launched India's first integrated oncology manufacturing facility with an investment of Rs 800 crore at at Genome Valley - Hyderabad's Life Sciences District, Biotech Park Phase III.

Inaugurated by IT and Industries Minister Sridhar Babu Duddilla, the state-of-the-art facility will produce oral oncology medicines, sterile injectables, lyophilised powder injections, and soft gel capsules using advanced containment technology for cancer care.

The unit is set to generate 500 direct jobs initially, with employment expected to double in the coming years.

The launch of this state-of-the-art facility marks another significant milestone in strengthening Telangana's position as a global life sciences and pharmaceutical manufacturing hub.